Literature DB >> 8628559

Clinical and surgical factors influencing corneal graft survival, visual acuity, and astigmatism. Corneal Transplant Follow-up Study Collaborators.

A Vail1, S M Gore, B A Bradley, D L Easty, C A Rogers, W J Armitate.   

Abstract

PURPOSE: To quantify clinical and operative factors that influence corneal graft outcome.
METHODS: A multifactorial analysis was done on 2242 corneal grafts registered by the United Kingdom Transplant Service from July 1987 to June 1991.
RESULTS: There was an increased risk of graft failure in patients with preoperative diffuse and other noncentral stromal edema, less-common eye diseases, small trephine size, difference in donor and recipient sizes greater than 0.25 mm, and use of mixed continuous and interrupted sutures. Visual acuity 3 months after surgery was poorer in patients who had glaucoma and low visual acuity preoperatively, small trephine size, and combined vitreous surgery. Use of interrupted sutures resulted in higher astigmatism at 3 months.
CONCLUSIONS: After allowing for the effects of recipient factors, surgical factors significantly affected corneal graft outcome. No factors that showed significant benefits for graft survival also adversely affected visual performance. Details of medical history, clinical condition, and surgical method failed to predict more than a small proportion of observed variability in visual performance of functioning grafts.

Entities:  

Mesh:

Year:  1996        PMID: 8628559     DOI: 10.1016/s0161-6420(96)30734-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  10 in total

1.  [Current practice of immune prophylaxis and therapy in perforating keratoplasty. A survey of members of the Cornea Section of the German Ophthalmological Society].

Authors:  E Bertelmann; T Reinhard; U Pleyer
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

2.  [Postkeratoplasty astigmatism: comparison of three suturing techniques].

Authors:  I Naydis; M Klemm; A Hassenstein; G Richard; T Katz; S J Linke
Journal:  Ophthalmologe       Date:  2011-03       Impact factor: 1.059

3.  Comparison of refractive outcomes in three corneal transplantation techniques for keratoconus.

Authors:  Ting Huang; Yunwei Hu; Mengru Gui; Chao Hou; Hong Zhang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-08-14       Impact factor: 3.117

4.  Penetrating keratoplasty: outcomes from a corneal unit compared to national data.

Authors:  P Beckingsale; I Mavrikakis; N Al-Yousuf; E Mavrikakis; S M Daya
Journal:  Br J Ophthalmol       Date:  2006-06       Impact factor: 4.638

5.  Conclusions of the corneal transplant follow up study. Collaborating Surgeons.

Authors:  A Vail; S M Gore; B A Bradley; D L Easty; C A Rogers; W J Armitage
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

6.  A murine model of interlamellar corneal transplantation.

Authors:  C H Lau; S M Nicholls; D L Easty
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

7.  Donor organ cultured corneal tissue selection before penetrating keratoplasty.

Authors:  V M Borderie; S Scheer; O Touzeau; F Vedie; S Carvajal-Gonzalez; L Laroche
Journal:  Br J Ophthalmol       Date:  1998-04       Impact factor: 4.638

8.  Long-term results of penetrating keratoplasty. A 10-year-plus retrospective study.

Authors:  Marc Muraine; Christian Sanchez; Laure Watt; Alain Retout; Gérard Brasseur
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-06-18       Impact factor: 3.117

9.  MicroRNA-122 ameliorates corneal allograft rejection through the downregulation of its target CPEB1.

Authors:  Ting Wang; Fengjie Li; Wenwen Geng; Qingguo Ruan; Weiyun Shi
Journal:  Cell Death Discov       Date:  2017-05-15

10.  Novel adaptation of a running suture technique in a mouse model of corneal transplantation.

Authors:  Hayate Nakagawa; Tomas Blanco; Francesca Kahale; Rohan Bir Singh; Thomas H Dohlman; Reza Dana
Journal:  J Biol Methods       Date:  2021-10-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.